<em>Dealmaker’s Diary</em>: This $326B Pharma Giant’s 50% Crash Creates a 60% Profit Opportunity

Dealmaker’s Diary: This $326B Pharma Giant’s 50% Crash Creates a 60% Profit Opportunity

The market panicked and crushed this weight-loss drug leader by 50%. But the numbers tell a completely different story – one of expanding margins, global market penetration, and a pipeline that’s just getting started.


<em>Buy This, Not That</em>: Why This $8.8B Energy Company Embarrasses ExxonMobil

Buy This, Not That: Why This $8.8B Energy Company Embarrasses ExxonMobil

While ExxonMobil struggles with single-digit margins, this energy infrastructure company delivers 35% profitability and a dividend yield that crushes the competition.


<em>Monday Takeaways</em>: Why This Market Refuses to Fall

Monday Takeaways: Why This Market Refuses to Fall

Markets ignore Iran bombing as stocks push toward new highs. Powell testifies to Congress this week while PCE data Friday could shake things up.


<em>Dealmaker’s Diary</em>: This $500M Company Profits From EVERY AI Device Made

Dealmaker’s Diary: This $500M Company Profits From EVERY AI Device Made

AI “pick and shovel” plays are all the rage… but this power module specialist makes money from every AI device that gets plugged in – with 57% margins to prove it.


<em>Buy This, Not That</em>: Spain Offers Better Yields Than Italy in ETF Battle

Buy This, Not That: Spain Offers Better Yields Than Italy in ETF Battle

European markets outpace the US in 2025, but which country ETF deserves your investment dollars? The answer lies in a powerful Spanish bank.


<em>Monday Takeaways</em>: The 3 Market Signals That Reveal What’s Coming Next

Monday Takeaways: The 3 Market Signals That Reveal What’s Coming Next

While headlines screamed about geopolitical chaos, smart money was reading three specific market signals that historically precede major moves. Here’s what they saw – and what it means for your portfolio.


<em>Dealmaker’s Diary</em>: How a 32-Year “Sleeper” Just Delivered 186% Growth

Dealmaker’s Diary: How a 32-Year “Sleeper” Just Delivered 186% Growth

This 32-year infrastructure stock just shocked Wall Street with 186% net income growth. Sometimes the best opportunities come from proven performers going explosive.


<em>Buy This, Not That</em>: Don’t Be Fooled by This Steel Stock’s 37% Surge

Buy This, Not That: Don’t Be Fooled by This Steel Stock’s 37% Surge

One steel stock crashed 65% from its highs but just bounced 37%. Its rival trades sideways but generates massive cash flow. See which deserves your money.


<em>Monday Takeaways</em>: Apple and Tesla Face Their Biggest Tests of 2025

Monday Takeaways: Apple and Tesla Face Their Biggest Tests of 2025

Apple kicks off its crucial developers conference while Tesla prepares to unveil robotaxi technology – both stocks “beaten up pretty hard” and desperately needing wins to catch up with Magnificent Seven peers.


<em>Dealmaker’s Diary</em>: Why This “Boring” Stock with a 32-Year Dividend Streak Could Dominate the Next Decade

Dealmaker’s Diary: Why This “Boring” Stock with a 32-Year Dividend Streak Could Dominate the Next Decade

This water tech giant has a 32-year dividend streak and one of the highest alpha’s Alpesh has ever seen. Here’s why boring beats flashy every time.


BROUGHT TO YOU BY MANWARD PRESS